Patients with relapsing-remitting multiple sclerosis ( age @-@ years , with Expanded Disability Status Scale score @ ) were randomly assigned ( @:@:@ ) via an interactive voice response or web system , and stratified by site , to placebo or subcutaneous peginterferon beta-@a @ g once every @ weeks or every @ weeks .